Saturday, November 14, 2026

GBP/EUR Is 1% Up In The Last 10 Sessions

ViaNews Editorial Team

September 26, 2024

Automated market report from our archive (2020–2024), published before source-traceability. How we work

GBP/EUR Is 1% Up In The Last 10 Sessions

(VIANEWS) - GBP/EUR (GBPEUR) has been up by 1.15% for the last 10 sessions. At 08:07 EST on Thursday, 26 September, GBP/EUR (GBPEUR) is $1.20.

GBP/EUR's yearly highs and lows, it's 5.093% up from its 52-week low and 0.283% down from its 52-week high.

News about

  • According to FXStreet on Thursday, 26 September, "On the upside, the USD/JPY pair may explore the region around its six-week high of 149.40.", "In terms of support, the USD/JPY pair may test the immediate upper boundary of the descending channel, around the 144.00 level, followed by the nine-day Exponential Moving Average (EMA) at the level of 143.62. "
  • According to FXStreet on Wednesday, 25 September, "The strong recovery in the US Dollar and US yields across the board motivated USD/JPY to leave behind two daily pullbacks in a row and retest the upper-144.00s. "
  • Usd/jpy price forecast: struggles at 144.00 tumbles after hitting two-week peak. According to FXStreet on Tuesday, 24 September, "The USD/JPY retreats after hitting a two-week high of 144.68, sliding some 0.28%. ", "Conversely, if USD/JPY edged toward the Kijun-Sen at 143.44 and clears that level, the pair could aim to challenge 144.00. "
  • According to FXStreet on Tuesday, 24 September, "On the downside, the USD/JPY pair may test the nine-day EMA at the 143.01 level. ", "The USD/JPY pair may weaken due to increasing expectations for further rate cuts by the US Federal Reserve (Fed) in 2024. "
  • Usd/jpy holds steady above 143.00 despite softer US dollar. According to FXStreet on Wednesday, 25 September, "The USD/JPY pair trades flat near 143.20 despite the weaker US Dollar (USD) during the early Asian session on Wednesday. "

More news about GBP/EUR (GBPEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com